<?xml version="1.0" encoding="UTF-8"?>
<doi_batch version="4.4.2" xmlns="http://www.crossref.org/schema/4.4.2" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:jats="http://www.ncbi.nlm.nih.gov/JATS1" xsi:schemaLocation="http://www.crossref.org/schema/4.4.2 http://www.crossref.org/schema/deposit/crossref4.4.2.xsd">
<head>
<doi_batch_id>396e3d57186c1f28fcb-7403</doi_batch_id>
<timestamp>20230317055002095</timestamp>
<depositor>
  <depositor_name>beie:beie</depositor_name> 
  <email_address>director@blueeyesintelligence.org</email_address>
</depositor>
<registrant>WEB-FORM</registrant> 
</head>
<body>
<journal>
<journal_metadata>   <full_title>International Journal of Innovative Technology and Exploring Engineering</full_title>   <abbrev_title>IJITEE</abbrev_title>   <issn media_type='electronic'>22783075</issn>   <doi_data>     <doi>10.35940/ijitee</doi>     <resource>https://www.ijitee.org/</resource>   </doi_data> </journal_metadata> <journal_issue>  <publication_date media_type='online'>     <month>04</month>     <day>30</day>     <year>2023</year>   </publication_date>   <journal_volume>     <volume>12</volume>   </journal_volume>   <issue>5</issue> </journal_issue><!-- ============== --> <journal_article publication_type='full_text'>   <titles>     <title>Design, Fabrication and Characterization of Antiemetic Transdermal Patches Loaded Dissolvable Microneedles</title>   </titles>   <contributors>      <organization sequence='first' contributor_role='author'>Department of Pharmaceutics, Research Scholar, Bhagwant University, Ajmer (Rajasthan), India</organization>    <person_name sequence='first' contributor_role='author'>      <given_name>Deepesh</given_name>      <surname>Lall</surname>      <ORCID>https://orcid.org/0000-0001-9928-5226</ORCID>    </person_name>    <person_name sequence='additional' contributor_role='author'>       <given_name>Dr. Neeraj</given_name>       <surname>Sharma</surname>     </person_name>     <organization sequence='additional' contributor_role='author'>Department of Pharmaceutics, Professor/ Principal, Bhagwant University, Ajmer (Rajasthan), India</organization>     <person_name sequence='additional' contributor_role='author'>       <given_name>Dr. Shruti Rathore, </given_name>       <surname>Rathore</surname>       <ORCID>https://orcid.org/0000-0001-6311-6543</ORCID>     </person_name>     <organization sequence='additional' contributor_role='author'>Department of Pharmaceutics, Professor/ Principal, LCIT School of Pharmacy, Bilaspur (Chhattisgarh), India</organization>   </contributors>    <jats:abstract xml:lang='en'>         <jats:p>Various non-invasive administration has been recently coming as an excellent alternative to conventional administrative mechanism. A transdermal drug delivery system with polymeric microneedles presents the most attractive method among all these because of its low rejection rate, higher bioavailability, super convenience, ease of administration and ease of termination, biodegradable and persistence in the skin care industry. However, the skin physiochemical properties made them to protect the inner environment and this mechanism play as excellent barrier for TDDS, hence polymeric bio dissolvable and biocompatible microneedle can be excellent choice. In this research, we fabricated and characterized the different proportions of polymer blend solution for effective and improved bioavailability and delivery of Ondansetron HCl. We characterized TDDS on progression of mechanically strength determination by folding endurance, flatness study, gelatin sheets beds penetration application, percentage drug content releasement under FT-IR and studied microscopic images the shape and size of microneedle. In addition, desired physical properties and an excellent alternative method had been established with high efficiency inherent to TDDS which expected to find a broad range of application fields.</jats:p>     </jats:abstract>  <publication_date media_type='online'>     <month>04</month>     <day>30</day>     <year>2023</year>   </publication_date>   <pages>     <first_page>12</first_page>     <last_page>17</last_page>   </pages>   <crossmark>     <crossmark_version>CC BY-NC-ND 4.0</crossmark_version>     <crossmark_policy>10.35940/BEIESP.CrossMarkPolicy</crossmark_policy>     <crossmark_domains>       <crossmark_domain>          <domain>www.ijitee.org</domain>       </crossmark_domain>     </crossmark_domains>     <crossmark_domain_exclusive>true</crossmark_domain_exclusive>     <custom_metadata>       <assertion explanation='Funding' group_label='Funding' group_name='Funding' name='Declaration' order='0'>No, I did not receive.</assertion>       <assertion explanation='Conflicts of Interest' group_label='Conflicts of Interest' group_name='Conflicts-of-Interest' name='Declaration' order='1'>No conflicts of interest to the best of our knowledge.</assertion>       <assertion explanation='Ethical Approval and Consent to Participate' group_label='Ethical Approval and Consent to Participate' group_name='Ethical-Approval-and-Consent-to-Participate' name='Declaration' order='2'>No, the article does not require ethical approval and consent to participate with evidence.</assertion>       <assertion explanation='Availability of Data and Material' group_label='Availability of Data and Material' group_name='Availability-of-Data-and-Material' name='Declaration' order='3'>Not relevant.</assertion>       <assertion explanation='Authors Contributions' group_label='Authors Contributions' group_name='Authors-Contributions' name='Declaration' order='4'>All authors have equal participation in this article.</assertion>     </custom_metadata>   </crossmark>   <doi_data>     <doi>10.35940/ijitee.E9493.0412523</doi>     <resource>https://www.ijitee.org/portfolio-item/E94930412523/</resource>   </doi_data> </journal_article>
</journal>
</body>
</doi_batch>
